VEGFR2 deletion increases susceptibility to photoreceptor degeneration through glial-neuronal interaction
Christina B. Bielmeier, Sabrina I. Schmitt, Verena Lehr, Anita Grundl, Andrea E. Dillinger, Herbert Jägle, Christine von Toerne, Stefanie M. Hauck, Süleyman Ergün, Ernst R. Tamm, Anja Schlecht, Andreas Neueder, Barbara M. Braunger · 2026
Read VEGFR2 deletion increases susceptibility to photoreceptor degeneration through glial-neuronal interaction by Christina B. Bielmeier, Sabrina I. Schmitt, Verena Lehr, Anita Grundl, Andrea E. Dillinger, Herbert Jägle, Christine von Toerne, Stefanie M. Hauck, Süleyman Ergün, Ernst R. Tamm, Anja Schlecht, Andreas Neueder, Barbara M. Braunger (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13260824.txt.
Description
Christina Bielmeier and twelve colleagues published an eye study in two thousand twenty-six on a side risk of common eye injections. Drugs that block the growth factor VEGF treat wet macular degeneration well. Yet reports link them to faster wasting in the dry form of the disease.
The team used mice whose eyes could be switched to lack a VEGF receptor. Normal eyes looked and worked fine without the signal. Under damaging light, however, receptor-free retinas lost far more light-sensing cells. A protective kinase pathway also fired less. Human data showed the receptor sits mainly in support glia, not the sensing cells. The authors infer a glia-to-neuron protection line that injections may weaken.
Catalog record
| CREATOR | Christina B. Bielmeier, Sabrina I. Schmitt, Verena Lehr, Anita Grundl, Andrea E. Dillinger, Herbert Jägle, Christine von Toerne, Stefanie M. Hauck, Süleyman Ergün, Ernst R. Tamm, Anja Schlecht, Andreas Neueder, Barbara M. Braunger |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 71 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |